Reporting on Adverse Clinical Events, 2018

DOI: 10.1177/0069477018776969

Keywords: Agomelatine (124),Baclofen (128),Clozapine (129),Dietary Supplements (130, 132),Fenitrothion (131),Fidaxomicin (127),Gabapentin (125),Heroin (120),Kratom (126),Nalmefene* (123),Ondansetron (121),Rivastigmine (119),Sacubitril/Valsartan* (122)

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text